|
Q3 2021
Filed on Oct 12, 2021
|
19,211
|
$14.11 - $17.12
$271K - $329K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
8,279
|
$34.9 - $50.9
$289K - $421K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
2,062
|
$215.2 - $231.51
$444K - $477K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
30,749
|
$22.01 - $25.1
$677K - $772K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
6,445
|
$36.67 - $39.02
$236K - $251K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
9,581
|
$23.99 - $35.49
$230K - $340K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
22,406
|
$53.74 - $59.94
$1.2M - $1.34M
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
7,254
|
$28.02 - $32.96
$203K - $239K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
4,979
|
$46.0 - $49.88
$229K - $248K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
6,381
|
$69.93 - $74.13
$446K - $473K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
15,313
|
$11.11 - $17.84
$170K - $273K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
6,208
|
$45.53 - $49.02
$283K - $304K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
11,710
|
$2.91 - $4.5
$34.1K - $52.7K
|
|
New Oriental Ed & Technology
|
Q3 2021
Filed on Oct 12, 2021
|
94,622
|
N/A
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
12,831
|
$52.32 - $55.93
$671K - $718K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
6,610
|
N/A
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
9,277
|
$29.2 - $36.72
$271K - $341K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
5,907
|
$41.44 - $45.27
$245K - $267K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
8,591
|
$107.61 - $119.12
$924K - $1.02M
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
7,118
|
$59.92 - $59.96
$427K - $427K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
2,078
|
$110.43 - $124.72
$229K - $259K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
28,208
|
$13.52 - $23.95
$381K - $676K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
54,473
|
N/A
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
28,851
|
$29.39 - $33.29
$848K - $960K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
39,411
|
$9.9 - $14.1
$390K - $556K
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Oct 12, 2021
|
9,064
|
N/A
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
424,974
|
N/A
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
5,802
|
$102.73 - $108.01
$596K - $627K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
4,613
|
$41.44 - $55.01
$191K - $254K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
3,244
|
$63.75 - $67.86
$207K - $220K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
74,019
|
$26.56 - $26.68
$1.97M - $1.97M
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
41,400
|
$46.48 - $49.7
$1.92M - $2.06M
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
14,610
|
$31.24 - $31.31
$456K - $457K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
3,988
|
$56.91 - $67.81
$227K - $270K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
5,625
|
$45.62 - $46.2
$257K - $260K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
4,832
|
$79.11 - $86.51
$382K - $418K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
2,817
|
$77.49 - $109.17
$218K - $308K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
12,552
|
$9.09 - $10.42
$114K - $131K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
4,716
|
$93.01 - $106.73
$439K - $503K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
14,384
|
$62.22 - $67.58
$895K - $972K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
5,114
|
$47.98 - $54.49
$245K - $279K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
3,049
|
$69.97 - $79.71
$213K - $243K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
18,416
|
$49.13 - $52.68
$905K - $970K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
4,541
|
$33.42 - $48.4
$152K - $220K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
1,901
|
$88.15 - $126.83
$168K - $241K
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
2,988
|
N/A
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
3,701
|
$109.98 - $113.55
$407K - $420K
|
|
Invesco Exch Traded Fd Tr Ii
|
Q3 2021
Filed on Oct 12, 2021
|
3,025
|
N/A
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
50,711
|
$27.24 - $27.55
$1.38M - $1.4M
|
|
|
Q3 2021
Filed on Oct 12, 2021
|
17,775
|
$109.9 - $121.42
$1.95M - $2.16M
|
|